Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

52.41
+0.45000.87%
Post-market: 52.420.0100+0.02%19:59 EDT
Volume:2.40M
Turnover:125.62M
Market Cap:106.01B
PE:16.76
High:52.57
Open:51.35
Low:51.35
Close:51.96
52wk High:61.70
52wk Low:38.63
Shares:2.02B
Float Shares:1.94B
Volume Ratio:0.71
T/O Rate:0.12%
Dividend:1.77
Dividend Rate:3.38%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.40
PE(LYR):14.03

Loading ...

Nuvalent Stock Jumps 39% on Surprise GSK Cancer-Drug Deal -- Barrons.com

Dow Jones
·
Jun 09

GSK's Nuvalent Deal Makes Strategic Sense -- Market Talk

Dow Jones
·
Jun 09

Video: Nuvalent jumps after GSK’s $10.6B takeover deal

TIPRANKS
·
Jun 09

J.P. Morgan Keeps Their Sell Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 09

Nuvalent Shares Soar Following GSK's Acquisition Announcement

Deep News
·
Jun 09

GSK's $10.6 Billion Acquisition of Nuvalent Bolsters Its Oncology Pipeline with Targeted Lung Cancer Drugs

Deep News
·
Jun 09

Nuvalent to Be Acquired by GSK in Cash Deal

TIPRANKS
·
Jun 09

Bernstein Gives a Buy Rating to GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 09

How a former lawyer is beating the stock market with these 11 picks

Dow Jones
·
Jun 09

UBS Remains a Hold on GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 09

Nuvalent Shares Leap Premarket on Takeover by GSK

Dow Jones
·
Jun 09

GlaxoSmithKline (GSK) Gets a Sell from Barclays

TIPRANKS
·
Jun 09

GlaxoSmithKline Announces $10.6 Billion Acquisition of US Biopharma Firm Nuvalent

Deep News
·
Jun 09

GSK's $10.6 Billion Nuvalent Deal Raises Eyebrows -- Market Talk

Dow Jones
·
Jun 09

Why a U.K. pharma giant is paying a 40% premium to pivot back to oncology

Dow Jones
·
Jun 09

GSK paying 40% premium to boost the cancer business it previously unwound

Dow Jones
·
Jun 09

GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down

Dow Jones
·
Jun 09

Dow Jones Top Company Headlines at 3 AM ET: GSK to Buy Nuvalent for $10.6 Billion in Oncology Push | University ...

Dow Jones
·
Jun 09

GSK to buy Nuvalent in $10.6bn deal to fast-track lung cancer push

TIPRANKS
·
Jun 09

Why GSK May Acquire Nuvalent — Report Points to $9B+ Deal Talks

TIPRANKS
·
Jun 09